Global CNS Therapeutics Strategic Report 2023: Market to Reach $199 Billion by 2030 - Developing Market to Drive the Market Momentum, Asia-Pacific to Exhibit Fastest Growth
November 30, 2023 05:38 ET
|
Research and Markets
Dublin, Nov. 30, 2023 (GLOBE NEWSWIRE) -- The "CNS Therapeutics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global CNS Therapeutics Market to...
Multiple Sclerosis Pipeline Insights | Clinical Trials Evaluation Report 2022 | DelveInsight
July 06, 2022 12:00 ET
|
DelveInsight Business Research LLP
Las Vegas, USA, July 06, 2022 (GLOBE NEWSWIRE) -- Multiple Sclerosis Pipeline Insights | Clinical Trials Evaluation Report 2022 | DelveInsight As per DelveInsight Multiple Sclerosis pipeline...
Global CNS Therapeutics Market to Cross $132 Billion by 2024 - Unmet Healthcare Needs for Detecting & Treating CNS Conditions Brings to Fore the Untapped Market Potential
March 22, 2022 05:53 ET
|
Research and Markets
Dublin, March 22, 2022 (GLOBE NEWSWIRE) -- The "CNS Therapeutics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global CNS Therapeutics...
Global Multiple Sclerosis Industry Review 2018-2020 with Forecasts to 2026 - Market Size by Country, Competitor Drug Sales, Market Shares, and More
December 24, 2021 06:58 ET
|
Research and Markets
Dublin, Dec. 24, 2021 (GLOBE NEWSWIRE) -- The "Global Multiple Sclerosis Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. This report provides...
Insights on the CNS Therapeutics Global Market to 2025 - Featuring AbbVie, Alkermes and Allergan Among Others
April 13, 2021 08:13 ET
|
Research and Markets
Dublin, April 13, 2021 (GLOBE NEWSWIRE) -- The "CNS Therapeutics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The global market for CNS...